International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 6.11.2020
Truth and Consequences in a Time of Racism and COVID-19
The dual dramas of anti-racism protests and a pandemic occupied the world stage again this week. Dr. Brian G.M. Durie examines the health impact of both, and offers science-based guidance for patients weighing the risks of resuming everyday activities.
Watch Dr. Joseph Mikhael’s Overview of ASCO 2020
In this video, IMF Chief Medical Officer Dr. Joseph Mikhael discusses the top multiple myeloma abstracts from the American Society of Clinical Oncology (ASCO) 2020 virtual meeting. Topics include the ENDURANCE trial, which compares two common myeloma triplet combination therapies (VRd v. KRd); CAR T-cell therapy; the bispecific antibody teclistamab; the antibody-drug conjugate belantamab mafodotin; and the StaMINA trial.
Pivotal Data from Phase 3 BOSTON Trial Presented at ASCO 2020
Presented at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, “the BOSTON study evaluated once-weekly XPOVIO® (selinexor) in combination with once-weekly Velcade® (bortezomib) and low-dose dexamethasone (40mg weekly) (SVd) compared to standard twice-weekly Velcade plus low-dose dexamethasone (80mg weekly) (Vd) in patients with multiple myeloma who have received one to three prior lines of therapy.”
Register Now for the 8th Annual Miracles for Myeloma 5K Virtual Run/Walk
Join the 8th Annual Miracles for Myeloma 5K Virtual Run/Walk on Saturday, September 26, 2020. Participate from September 1-26, 2020, alongside registrants from around the world. You can either sign up individually, sign up with a virtual team, or join an existing virtual team. For those who are not running, cycling, walking, or “treadmill-ing,” explore the option of honoring someone on the Remembrance Path.
Celebrate Dad and Give to the IMF at the Same Time
Father’s Day is Sunday, June 21, 2020. When you shop and choose the International Myeloma Foundation as your preferred charity, Amazon donates a portion of your purchase to the IMF, at no added cost to you. Make your gift to Dad count twice this year!
Calling All Researchers: Submit Your Grant Applications
The Brian D. Novis Research Grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2021 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline to receive the applications is Saturday, August 1, 2020.
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

COVID-19 FAQ #14: Should myeloma patients undergo autologous stem cell transplant (ASCT) during the pandemic? 
Watch Now
Clinical Trials

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
IMF Patient & Family Webinar Replay
Myeloma and Coronavirus

Hawaiian Vacation Raffle
Kailua-Kona, Hawaii

Hatfield Hike
Appalachian Trail

Click here to see all events

We Thank Our Sponsors:

Amgen, Bristol-Myers Squibb, Genentech, GSK, Sanofi-Genzyme, and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page